Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2022-04-01
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Studying Warmed Lidocaine for Increased Analgesic Effect During Intravitreal Injections
NCT06962709
Cooling Anesthesia for Intravitreal Injection
NCT03732287
The Effect of Needle Temperature on Pain Ratings Following Intramuscular Injection
NCT00213967
Cryospray to Reduce Pain During Venous Cannulation
NCT04865783
Investigating the Impact of Ice Application on the Venous Puncture Pain in the Pediatric Population
NCT06089889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ice-therapy
Ice therapy will be provided prior to the provision of the intravitreal injection
Ice-therapy
Ice therapy will be provided prior to intravitreal injection provision
No Ice-therapy
No ice therapy will be provided prior to the provision of the intravitreal injection
No Ice-therapy
No additional intervention (i.e.) ice therapy will be provided prior to intravitreal injection provision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ice-therapy
Ice therapy will be provided prior to intravitreal injection provision
No Ice-therapy
No additional intervention (i.e.) ice therapy will be provided prior to intravitreal injection provision
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jade Moon, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OPH-2022-30605
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.